• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

High resolution computed tomography (HRCT) in emphysema associated with alpha-1-antitrypsin deficiency.

作者信息

Guest P J, Hansell D M

机构信息

Department of Radiology, Royal Brompton National Heart and Lung Hospital, London.

出版信息

Clin Radiol. 1992 Apr;45(4):260-6. doi: 10.1016/s0009-9260(05)80011-x.

DOI:10.1016/s0009-9260(05)80011-x
PMID:1395384
Abstract

Alpha-1-antitrypsin (AAT) deficiency is an inherited disorder associated with an increased prevalence of pulmonary emphysema. To date there has been no description of the appearances on CT of the emphysema associated with AAT deficiency. We have reviewed the CT scans of 17 patients with proven AAT deficiency. Eleven out of 17 were examined with HRCT. The CT features were correlated with those on chest radiography. Areas of low density corresponding to parenchymal destruction and reduced perfusion, and attenuation of the pulmonary vasculature were present in all cases. Frank bulla formation occurred in 7/17 patients and was not a major feature. A striking CT finding was bronchial wall thickening and/or dilatation in 7/17 patients with gross cystic bronchiectasis in one patient. In contrast to appearances on chest radiography the upper zones were affected in all cases (17/17) and fine section scanning was particularly valuable in demonstrating changes in these less severely affected regions. Estimation of the extent of disease correlated well with abnormal lung function tests.

摘要

相似文献

1
High resolution computed tomography (HRCT) in emphysema associated with alpha-1-antitrypsin deficiency.
Clin Radiol. 1992 Apr;45(4):260-6. doi: 10.1016/s0009-9260(05)80011-x.
2
Relations between cardiopulmonary exercise testing and quantitative high-resolution computed tomography associated in patients with alpha-1-antitrypsin deficiency.α-1抗胰蛋白酶缺乏症患者心肺运动试验与定量高分辨率计算机断层扫描之间的关系。
Eur J Med Res. 1998 Nov 17;3(11):527-32.
3
[Bronchiectasis and infection incidence in alpha 1-antitrypsin deficiency. The value of high-resolution computed tomography].α1抗胰蛋白酶缺乏症中的支气管扩张与感染发生率。高分辨率计算机断层扫描的价值
Rofo. 1995 Nov;163(5):378-82. doi: 10.1055/s-2007-1016012.
4
Bronchiectasis in patients with alpha 1-antitrypsin deficiency. A rare occurrence?
Chest. 1993 Nov;104(5):1384-6. doi: 10.1378/chest.104.5.1384.
5
[New method of scoring lung changes using computed tomography in patients with cystic fibrosis].[在囊性纤维化患者中使用计算机断层扫描对肺部变化进行评分的新方法]
Med Wieku Rozwoj. 2012 Oct-Dec;16(4):290-302.
6
Alpha 1-antitrypsin deficiency: evaluation of bronchiectasis with CT.α1抗胰蛋白酶缺乏症:CT评估支气管扩张
Radiology. 1996 Apr;199(1):137-41. doi: 10.1148/radiology.199.1.8633137.
7
Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial.静脉增强治疗与严重 α1 抗胰蛋白酶缺乏症(RAPID)的肺密度:一项随机、双盲、安慰剂对照试验。
Lancet. 2015 Jul 25;386(9991):360-8. doi: 10.1016/S0140-6736(15)60860-1. Epub 2015 May 27.
8
Progress of emphysema in severe alpha 1-antitrypsin deficiency as assessed by annual CT.通过年度CT评估严重α1-抗胰蛋白酶缺乏症患者肺气肿的进展情况。
Acta Radiol. 1997 Sep;38(5):826-32. doi: 10.1080/02841859709172418.
9
Prevalence and impact of bronchiectasis in alpha1-antitrypsin deficiency.α1-抗胰蛋白酶缺乏症中支气管扩张的患病率及影响
Am J Respir Crit Care Med. 2007 Dec 15;176(12):1215-21. doi: 10.1164/rccm.200703-489OC. Epub 2007 Sep 13.
10
Exploring the optimum approach to the use of CT densitometry in a randomised placebo-controlled study of augmentation therapy in alpha 1-antitrypsin deficiency.在一项关于α1抗胰蛋白酶缺乏症增强疗法的随机安慰剂对照研究中探索CT密度测定法的最佳使用方法。
Respir Res. 2009 Aug 13;10(1):75. doi: 10.1186/1465-9921-10-75.

引用本文的文献

1
Antitrypsin deficiency: still more to learn about the lung after 60 years.抗胰蛋白酶缺乏症:60年后肺部仍有更多有待了解之处。
ERJ Open Res. 2024 Jul 22;10(4). doi: 10.1183/23120541.00139-2024. eCollection 2024 Jul.
2
The prevalence of bronchiectasis in patients with alpha-1 antitrypsin deficiency: initial report of EARCO.α-1 抗胰蛋白酶缺乏症患者支气管扩张症的患病率:EARCO 的初步报告。
Orphanet J Rare Dis. 2023 Aug 12;18(1):243. doi: 10.1186/s13023-023-02830-2.
3
Impact of Bronchiectasis on COPD Severity and Alpha-1 Antitrypsin Deficiency as a Risk Factor in Individuals with a Heavy Smoking History.
支气管扩张症对慢性阻塞性肺疾病严重程度的影响以及α-1抗胰蛋白酶缺乏作为重度吸烟史个体的危险因素
Chronic Obstr Pulm Dis. 2023 Jul 26;10(3):199-210. doi: 10.15326/jcopdf.2023.0388.
4
Lung Imaging in COPD Part 1: Clinical Usefulness.COPD 的肺部影像学表现(一):临床应用价值。
Chest. 2023 Jul;164(1):69-84. doi: 10.1016/j.chest.2023.03.007. Epub 2023 Mar 11.
5
Augmentation therapy with human alpha-1-proteinase inhibitor reduces exacerbations in patient with bronchiectasis and alpha-1-antitrypsin deficiency.用人α-1-蛋白酶抑制剂进行强化治疗可减少支气管扩张症和α-1抗胰蛋白酶缺乏症患者的病情加重。
Respir Med Case Rep. 2022 Sep 14;39:101740. doi: 10.1016/j.rmcr.2022.101740. eCollection 2022.
6
Alpha-1 Asthma Overlap Syndrome: a Clinical Overview.α1 型哮喘重叠综合征:临床概述。
Curr Allergy Asthma Rep. 2022 Sep;22(9):101-111. doi: 10.1007/s11882-022-01036-z. Epub 2022 May 20.
7
The Distribution of Alpha-1 Antitrypsin Genotypes Between Patients with COPD/Emphysema, Asthma and Bronchiectasis.α-1 抗胰蛋白酶基因型在 COPD/肺气肿、哮喘和支气管扩张症患者中的分布。
Int J Chron Obstruct Pulmon Dis. 2020 Nov 6;15:2827-2836. doi: 10.2147/COPD.S271810. eCollection 2020.
8
Non-tuberculous mycobacterial lung disease due to multiple "minor" risk factors: an illustrative case and a review of these "lesser elements".由多种“次要”风险因素导致的非结核分枝杆菌肺病:一个实例及对这些“次要因素”的综述
J Thorac Dis. 2020 Sep;12(9):4960-4972. doi: 10.21037/jtd-20-986.
9
Pathophysiology and Genetics of Bronchiectasis Unrelated to Cystic Fibrosis.非囊性纤维化相关支气管扩张症的病理生理学和遗传学。
Lung. 2018 Aug;196(4):383-392. doi: 10.1007/s00408-018-0121-y. Epub 2018 May 12.
10
Lung densitometry: why, how and when.肺密度测定法:为何、如何及何时进行
J Thorac Dis. 2017 Sep;9(9):3319-3345. doi: 10.21037/jtd.2017.08.17.